Scilex Holding Co (SCLX)
0.8655
+0.01
(+0.64%)
USD |
NASDAQ |
May 06, 16:00
0.888
+0.02
(+2.60%)
Pre-Market: 09:05
Scilex Total Assets (Quarterly): 101.31M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.31M |
| September 30, 2023 | 80.53M |
| June 30, 2023 | 126.46M |
| Date | Value |
|---|---|
| March 31, 2023 | 86.05M |
| December 31, 2022 | 86.53M |
| September 30, 2022 | 88.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
80.53M
Minimum
Sep 2023
126.46M
Maximum
Jun 2023
94.94M
Average
87.65M
Median
Total Assets (Quarterly) Benchmarks
| Sorrento Therapeutics Inc | 456.69M |
| Adial Pharmaceuticals Inc | 4.737M |
| Precision BioSciences Inc | 159.78M |
| Humacyte Inc | 128.22M |
| Perspective Therapeutics Inc | 97.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 274.25M |
| Shareholders Equity (Quarterly) | -172.94M |
| Debt to Equity Ratio | -0.7255 |
| Current Ratio | 0.1868 |
| Net Debt Paydown Yield | -1.53% |